[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fy2BpcIlwi6FNvjAK9JscnKu0H9bmiqtAr6xJZl2cUQM":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":31,"phaseBuckets":37,"rows":44},"Hospital Italiano de Buenos Aires",[4],121,false,13,5,14152616,1,99,[14,16,18,21,23,25,27,29],{"name":15,"count":9},"COPD",{"name":17,"count":9},"COVID-19",{"name":19,"count":20},"Appointments and Schedules",3,{"name":22,"count":20},"Covid19",{"name":24,"count":20},"Death",{"name":26,"count":20},"Carpal Tunnel Syndrome",{"name":28,"count":20},"Multiple Sclerosis",{"name":30,"count":20},"Bacterial Infections",[32],{"nctId":33,"briefTitle":34,"date":35,"intervention":36},"NCT07621419","Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin","2027-12-31","semaglutide",[38,39,40,41,42,43],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[45,69,98,116,141,167,197,215,241,266,284,308,335,360,390,408,426,454,472,490,518,536,560,597,625,643,669,696,714,740,764],{"intervention":36,"totalTrials":11,"cells":46},{"EARLY_PHASE1":47,"PHASE1":50,"PHASE2":52,"PHASE3":54,"PHASE4":56,"NA":58},{"trials":48,"activeCount":49},[],0,{"trials":51,"activeCount":49},[],{"trials":53,"activeCount":49},[],{"trials":55,"activeCount":49},[],{"trials":57,"activeCount":49},[],{"trials":59,"activeCount":11,"soonestReadout":35},[60],{"nctId":33,"briefTitle":34,"status":61,"phases":62,"primaryCompletion":35,"completion":63,"start":64,"enrollment":65,"conditions":66,"interventions":68},"RECRUITING",[],"2028-12-31","2025-08-04",145,[67],"Diabetes Mellitus",[36],{"intervention":70,"totalTrials":11,"cells":71},"Atenolol",{"EARLY_PHASE1":72,"PHASE1":74,"PHASE2":76,"PHASE3":78,"PHASE4":80,"NA":96},{"trials":73,"activeCount":49},[],{"trials":75,"activeCount":49},[],{"trials":77,"activeCount":49},[],{"trials":79,"activeCount":49},[],{"trials":81,"activeCount":49},[82],{"nctId":83,"briefTitle":84,"status":85,"phases":86,"primaryCompletion":87,"completion":88,"start":89,"enrollment":90,"conditions":91,"interventions":94},"NCT01939509","Hemodynamic Changes of Patients Receiving Atenolol\u002FBisoprolol","COMPLETED",[42],"2014-10","2014-11","2012-02",80,[92,93],"Hypertension","Metabolic Syndrome",[70,95],"Bisoprolol",{"trials":97,"activeCount":49},[],{"intervention":95,"totalTrials":11,"cells":99},{"EARLY_PHASE1":100,"PHASE1":102,"PHASE2":104,"PHASE3":106,"PHASE4":108,"NA":114},{"trials":101,"activeCount":49},[],{"trials":103,"activeCount":49},[],{"trials":105,"activeCount":49},[],{"trials":107,"activeCount":49},[],{"trials":109,"activeCount":49},[110],{"nctId":83,"briefTitle":84,"status":85,"phases":111,"primaryCompletion":87,"completion":88,"start":89,"enrollment":90,"conditions":112,"interventions":113},[42],[92,93],[70,95],{"trials":115,"activeCount":49},[],{"intervention":117,"totalTrials":11,"cells":118},"Ketamine",{"EARLY_PHASE1":119,"PHASE1":121,"PHASE2":123,"PHASE3":125,"PHASE4":127,"NA":139},{"trials":120,"activeCount":49},[],{"trials":122,"activeCount":49},[],{"trials":124,"activeCount":49},[],{"trials":126,"activeCount":49},[],{"trials":128,"activeCount":49},[129],{"nctId":130,"briefTitle":131,"status":85,"phases":132,"primaryCompletion":133,"completion":133,"start":134,"enrollment":135,"conditions":136,"interventions":138},"NCT00978757","The Effect of Ketamine on Interleukin-6 Synthesis in Hepatic Resections Requiring Temporary Porto-arterial Occlusion",[42],"2008-06","2001-06",42,[137],"Hepatectomy",[117],{"trials":140,"activeCount":49},[],{"intervention":142,"totalTrials":11,"cells":143},"Amoxicillin clavulanic",{"EARLY_PHASE1":144,"PHASE1":146,"PHASE2":148,"PHASE3":150,"PHASE4":152,"NA":165},{"trials":145,"activeCount":49},[],{"trials":147,"activeCount":49},[],{"trials":149,"activeCount":49},[],{"trials":151,"activeCount":49},[],{"trials":153,"activeCount":49},[154],{"nctId":155,"briefTitle":156,"status":85,"phases":157,"primaryCompletion":158,"completion":159,"start":160,"enrollment":161,"conditions":162,"interventions":164},"NCT02057679","Extended Antibiotic Therapy in Postoperative of Laparoscopic Cholecystectomy in Acute Cholecystitis",[42],"2017-03","2018-05","2014-02",200,[163],"Acute Cholecystitis",[142],{"trials":166,"activeCount":49},[],{"intervention":168,"totalTrials":11,"cells":169},"Propofol",{"EARLY_PHASE1":170,"PHASE1":172,"PHASE2":174,"PHASE3":176,"PHASE4":178,"NA":195},{"trials":171,"activeCount":49},[],{"trials":173,"activeCount":49},[],{"trials":175,"activeCount":49},[],{"trials":177,"activeCount":49},[],{"trials":179,"activeCount":49},[180],{"nctId":181,"briefTitle":182,"status":183,"phases":184,"primaryCompletion":185,"completion":186,"start":187,"enrollment":188,"conditions":189,"interventions":193},"NCT02999126","Slow Stepwise Propofol TCI Induction for Titration Anesthesia Maintenance","UNKNOWN",[42],"2020-12","2021-03","2016-08",60,[190,191,192],"Target Controlled Infusion","Induction of Anesthesia","Bispectral Index",[168,194],"Remifentanil Hydrochloride",{"trials":196,"activeCount":49},[],{"intervention":194,"totalTrials":11,"cells":198},{"EARLY_PHASE1":199,"PHASE1":201,"PHASE2":203,"PHASE3":205,"PHASE4":207,"NA":213},{"trials":200,"activeCount":49},[],{"trials":202,"activeCount":49},[],{"trials":204,"activeCount":49},[],{"trials":206,"activeCount":49},[],{"trials":208,"activeCount":49},[209],{"nctId":181,"briefTitle":182,"status":183,"phases":210,"primaryCompletion":185,"completion":186,"start":187,"enrollment":188,"conditions":211,"interventions":212},[42],[190,191,192],[168,194],{"trials":214,"activeCount":49},[],{"intervention":216,"totalTrials":11,"cells":217},"Mosapride",{"EARLY_PHASE1":218,"PHASE1":220,"PHASE2":222,"PHASE3":224,"PHASE4":226,"NA":239},{"trials":219,"activeCount":49},[],{"trials":221,"activeCount":49},[],{"trials":223,"activeCount":49},[],{"trials":225,"activeCount":49},[],{"trials":227,"activeCount":49},[228],{"nctId":229,"briefTitle":230,"status":183,"phases":231,"primaryCompletion":232,"completion":233,"start":234,"enrollment":235,"conditions":236,"interventions":238},"NCT02056405","Effect of Mosapride on Postoperative Ileus in Patients Undergoing Colorectal Surgery",[42],"2016-12","2017-12","2015-12",90,[237],"Postoperative Ileus",[216],{"trials":240,"activeCount":49},[],{"intervention":242,"totalTrials":11,"cells":243},"phosphate and betamethasone acetate, 2 mL.",{"EARLY_PHASE1":244,"PHASE1":246,"PHASE2":248,"PHASE3":250,"PHASE4":252,"NA":264},{"trials":245,"activeCount":49},[],{"trials":247,"activeCount":49},[],{"trials":249,"activeCount":49},[],{"trials":251,"activeCount":49},[],{"trials":253,"activeCount":49},[254],{"nctId":255,"briefTitle":256,"status":183,"phases":257,"primaryCompletion":232,"completion":233,"start":258,"enrollment":259,"conditions":260,"interventions":262},"NCT02652884","Steroids in the Postoperative Transient Hypoparathyroidism Total Thyroidectomy",[42],"2016-01",110,[261],"Transient Hypoparathyroidism",[242,263],"saline 0.9% NaCl",{"trials":265,"activeCount":49},[],{"intervention":263,"totalTrials":11,"cells":267},{"EARLY_PHASE1":268,"PHASE1":270,"PHASE2":272,"PHASE3":274,"PHASE4":276,"NA":282},{"trials":269,"activeCount":49},[],{"trials":271,"activeCount":49},[],{"trials":273,"activeCount":49},[],{"trials":275,"activeCount":49},[],{"trials":277,"activeCount":49},[278],{"nctId":255,"briefTitle":256,"status":183,"phases":279,"primaryCompletion":232,"completion":233,"start":258,"enrollment":259,"conditions":280,"interventions":281},[42],[261],[242,263],{"trials":283,"activeCount":49},[],{"intervention":285,"totalTrials":11,"cells":286},"Gabapentin",{"EARLY_PHASE1":287,"PHASE1":289,"PHASE2":291,"PHASE3":293,"PHASE4":295,"NA":306},{"trials":288,"activeCount":49},[],{"trials":290,"activeCount":49},[],{"trials":292,"activeCount":49},[],{"trials":294,"activeCount":49},[],{"trials":296,"activeCount":49},[297],{"nctId":298,"briefTitle":299,"status":85,"phases":300,"primaryCompletion":258,"completion":301,"start":234,"enrollment":302,"conditions":303,"interventions":305},"NCT02693821","Persistent Postoperative Pain Incidence With Gabapentin Used",[42],"2022-06",122,[304],"Pain, Postoperative",[285],{"trials":307,"activeCount":49},[],{"intervention":309,"totalTrials":11,"cells":310},"Emtricitabine\u002FTenofovir Alafenamide 200 MG-25 MG Oral",{"EARLY_PHASE1":311,"PHASE1":313,"PHASE2":315,"PHASE3":317,"PHASE4":331,"NA":333},{"trials":312,"activeCount":49},[],{"trials":314,"activeCount":49},[],{"trials":316,"activeCount":49},[],{"trials":318,"activeCount":49},[319],{"nctId":320,"briefTitle":321,"status":322,"phases":323,"primaryCompletion":324,"completion":324,"start":325,"enrollment":326,"conditions":327,"interventions":330},"NCT04405271","TAF\u002FFTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)","TERMINATED",[41],"2020-11-15","2020-07-31",1378,[328,17,329],"Healthcare Workers","SARS-CoV 2",[309],{"trials":332,"activeCount":49},[],{"trials":334,"activeCount":49},[],{"intervention":336,"totalTrials":11,"cells":337},"Mupirocin",{"EARLY_PHASE1":338,"PHASE1":340,"PHASE2":342,"PHASE3":344,"PHASE4":356,"NA":358},{"trials":339,"activeCount":49},[],{"trials":341,"activeCount":49},[],{"trials":343,"activeCount":49},[],{"trials":345,"activeCount":49},[346],{"nctId":347,"briefTitle":348,"status":183,"phases":349,"primaryCompletion":350,"completion":233,"start":350,"enrollment":351,"conditions":352,"interventions":355},"NCT02963129","Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT",[41],"2017-06",40,[353,354],"Hereditary Hemorrhagic Telangiectasia","Epistaxis",[336],{"trials":357,"activeCount":49},[],{"trials":359,"activeCount":49},[],{"intervention":361,"totalTrials":11,"cells":362},"Buprenorphine",{"EARLY_PHASE1":363,"PHASE1":365,"PHASE2":367,"PHASE3":369,"PHASE4":386,"NA":388},{"trials":364,"activeCount":49},[],{"trials":366,"activeCount":49},[],{"trials":368,"activeCount":49},[],{"trials":370,"activeCount":49},[371],{"nctId":372,"briefTitle":373,"status":85,"phases":374,"primaryCompletion":375,"completion":376,"start":377,"enrollment":378,"conditions":379,"interventions":383},"NCT03380533","Buprenorphine Transdermal Patches in Arthroscopic Rotator Cuff Repair",[40,41],"2017-12-08","2021-04-06","2016-09-22",50,[380,381,382,361],"Rotator Cuff Tear","Rotator Cuff Injury","Analgesics, Opioid",[361,384,385],"Multimodal Oral Scheme","Tramadol",{"trials":387,"activeCount":49},[],{"trials":389,"activeCount":49},[],{"intervention":384,"totalTrials":11,"cells":391},{"EARLY_PHASE1":392,"PHASE1":394,"PHASE2":396,"PHASE3":398,"PHASE4":404,"NA":406},{"trials":393,"activeCount":49},[],{"trials":395,"activeCount":49},[],{"trials":397,"activeCount":49},[],{"trials":399,"activeCount":49},[400],{"nctId":372,"briefTitle":373,"status":85,"phases":401,"primaryCompletion":375,"completion":376,"start":377,"enrollment":378,"conditions":402,"interventions":403},[40,41],[380,381,382,361],[361,384,385],{"trials":405,"activeCount":49},[],{"trials":407,"activeCount":49},[],{"intervention":385,"totalTrials":11,"cells":409},{"EARLY_PHASE1":410,"PHASE1":412,"PHASE2":414,"PHASE3":416,"PHASE4":422,"NA":424},{"trials":411,"activeCount":49},[],{"trials":413,"activeCount":49},[],{"trials":415,"activeCount":49},[],{"trials":417,"activeCount":49},[418],{"nctId":372,"briefTitle":373,"status":85,"phases":419,"primaryCompletion":375,"completion":376,"start":377,"enrollment":378,"conditions":420,"interventions":421},[40,41],[380,381,382,361],[361,384,385],{"trials":423,"activeCount":49},[],{"trials":425,"activeCount":49},[],{"intervention":427,"totalTrials":11,"cells":428},"Cefazolin",{"EARLY_PHASE1":429,"PHASE1":431,"PHASE2":433,"PHASE3":435,"PHASE4":450,"NA":452},{"trials":430,"activeCount":49},[],{"trials":432,"activeCount":49},[],{"trials":434,"activeCount":49},[],{"trials":436,"activeCount":49},[437],{"nctId":438,"briefTitle":439,"status":85,"phases":440,"primaryCompletion":441,"completion":442,"start":443,"enrollment":444,"conditions":445,"interventions":447},"NCT01867138","Neonatal Suspected Sepsis Treated With Cefazolin or Vancomycin",[41],"2010-08","2011-01","2007-03",109,[446],"Nosocomial Neonatal Sepsis",[427,448,449],"Vancomycin","Amikacin",{"trials":451,"activeCount":49},[],{"trials":453,"activeCount":49},[],{"intervention":448,"totalTrials":11,"cells":455},{"EARLY_PHASE1":456,"PHASE1":458,"PHASE2":460,"PHASE3":462,"PHASE4":468,"NA":470},{"trials":457,"activeCount":49},[],{"trials":459,"activeCount":49},[],{"trials":461,"activeCount":49},[],{"trials":463,"activeCount":49},[464],{"nctId":438,"briefTitle":439,"status":85,"phases":465,"primaryCompletion":441,"completion":442,"start":443,"enrollment":444,"conditions":466,"interventions":467},[41],[446],[427,448,449],{"trials":469,"activeCount":49},[],{"trials":471,"activeCount":49},[],{"intervention":449,"totalTrials":11,"cells":473},{"EARLY_PHASE1":474,"PHASE1":476,"PHASE2":478,"PHASE3":480,"PHASE4":486,"NA":488},{"trials":475,"activeCount":49},[],{"trials":477,"activeCount":49},[],{"trials":479,"activeCount":49},[],{"trials":481,"activeCount":49},[482],{"nctId":438,"briefTitle":439,"status":85,"phases":483,"primaryCompletion":441,"completion":442,"start":443,"enrollment":444,"conditions":484,"interventions":485},[41],[446],[427,448,449],{"trials":487,"activeCount":49},[],{"trials":489,"activeCount":49},[],{"intervention":491,"totalTrials":11,"cells":492},"Dexamethasone",{"EARLY_PHASE1":493,"PHASE1":495,"PHASE2":497,"PHASE3":499,"PHASE4":514,"NA":516},{"trials":494,"activeCount":49},[],{"trials":496,"activeCount":49},[],{"trials":498,"activeCount":49},[],{"trials":500,"activeCount":49},[501],{"nctId":502,"briefTitle":503,"status":183,"phases":504,"primaryCompletion":505,"completion":506,"start":507,"enrollment":508,"conditions":509,"interventions":512},"NCT03374514","Cochlear Electrical Impedance and the Effect of Topical Dexamethasone on Cochlear Implant Surgery",[41],"2018-08","2018-11","2017-08-09",20,[510,511],"Sensorineural Hearing Loss","Cochlear Implant",[491,513],"Sterile isotonic saline solution",{"trials":515,"activeCount":49},[],{"trials":517,"activeCount":49},[],{"intervention":513,"totalTrials":11,"cells":519},{"EARLY_PHASE1":520,"PHASE1":522,"PHASE2":524,"PHASE3":526,"PHASE4":532,"NA":534},{"trials":521,"activeCount":49},[],{"trials":523,"activeCount":49},[],{"trials":525,"activeCount":49},[],{"trials":527,"activeCount":49},[528],{"nctId":502,"briefTitle":503,"status":183,"phases":529,"primaryCompletion":505,"completion":506,"start":507,"enrollment":508,"conditions":530,"interventions":531},[41],[510,511],[491,513],{"trials":533,"activeCount":49},[],{"trials":535,"activeCount":49},[],{"intervention":537,"totalTrials":11,"cells":538},"Suicide plus immunogene therapy",{"EARLY_PHASE1":539,"PHASE1":550,"PHASE2":552,"PHASE3":554,"PHASE4":556,"NA":558},{"trials":540,"activeCount":49},[541],{"nctId":542,"briefTitle":543,"status":322,"phases":544,"primaryCompletion":545,"completion":545,"start":545,"enrollment":546,"conditions":547,"interventions":549},"NCT03338777","Suicide Plus Immune Gene Therapy for Advanced Melanoma",[38],"2020-02-20",4,[548],"Melanoma",[537],{"trials":551,"activeCount":49},[],{"trials":553,"activeCount":49},[],{"trials":555,"activeCount":49},[],{"trials":557,"activeCount":49},[],{"trials":559,"activeCount":49},[],{"intervention":561,"totalTrials":562,"cells":563},"Lidocaine",2,{"EARLY_PHASE1":564,"PHASE1":566,"PHASE2":568,"PHASE3":570,"PHASE4":572,"NA":583},{"trials":565,"activeCount":49},[],{"trials":567,"activeCount":49},[],{"trials":569,"activeCount":49},[],{"trials":571,"activeCount":49},[],{"trials":573,"activeCount":49},[574],{"nctId":575,"briefTitle":576,"status":577,"phases":578,"start":579,"enrollment":49,"conditions":580,"interventions":582},"NCT01344252","Topical Jelly and Intracameral Anesthesia Versus Subtenon Anesthesia, in Cataract Surgery","WITHDRAWN",[42],"2011-04",[581],"Cataract Surgery Anesthesia",[561],{"trials":584,"activeCount":49},[585],{"nctId":586,"briefTitle":587,"status":85,"phases":588,"primaryCompletion":589,"completion":590,"start":591,"enrollment":592,"conditions":593,"interventions":595},"NCT05697276","Are There Differences in Postoperative Pain Between Bupivacaine and Lidocaine for Carpal Tunnel Release?",[43],"2023-08-07","2023-08-26","2022-09-13",82,[26,594],"Carpal Tunnel",[561,596],"Bupivacain",{"intervention":598,"totalTrials":11,"cells":599},"Pharmacogenomic index",{"EARLY_PHASE1":600,"PHASE1":602,"PHASE2":604,"PHASE3":606,"PHASE4":608,"NA":610},{"trials":601,"activeCount":49},[],{"trials":603,"activeCount":49},[],{"trials":605,"activeCount":49},[],{"trials":607,"activeCount":49},[],{"trials":609,"activeCount":49},[],{"trials":611,"activeCount":49},[612],{"nctId":613,"briefTitle":614,"status":85,"phases":615,"primaryCompletion":616,"completion":617,"start":618,"enrollment":619,"conditions":620,"interventions":624},"NCT03385473","Individualized Antiretroviral Therapy",[43],"2019-12-15","2019-12-31","2017-10-05",190,[621,622,623],"Pharmacogenetics","HIV","Drug Monitoring",[598],{"intervention":596,"totalTrials":11,"cells":626},{"EARLY_PHASE1":627,"PHASE1":629,"PHASE2":631,"PHASE3":633,"PHASE4":635,"NA":637},{"trials":628,"activeCount":49},[],{"trials":630,"activeCount":49},[],{"trials":632,"activeCount":49},[],{"trials":634,"activeCount":49},[],{"trials":636,"activeCount":49},[],{"trials":638,"activeCount":49},[639],{"nctId":586,"briefTitle":587,"status":85,"phases":640,"primaryCompletion":589,"completion":590,"start":591,"enrollment":592,"conditions":641,"interventions":642},[43],[26,594],[561,596],{"intervention":644,"totalTrials":11,"cells":645},"Tocilizumab",{"EARLY_PHASE1":646,"PHASE1":648,"PHASE2":650,"PHASE3":652,"PHASE4":654,"NA":656},{"trials":647,"activeCount":49},[],{"trials":649,"activeCount":49},[],{"trials":651,"activeCount":49},[],{"trials":653,"activeCount":49},[],{"trials":655,"activeCount":49},[],{"trials":657,"activeCount":49},[658],{"nctId":659,"briefTitle":660,"status":183,"phases":661,"primaryCompletion":662,"completion":663,"start":664,"enrollment":665,"conditions":666,"interventions":668},"NCT04924829","Safety and Effectiveness Study of Tocilizumab in Patients With Severe COVID-19",[],"2021-07-01","2021-08-01","2021-06-01",300,[667,644],"Severe COVID 19 Pneumonia",[644],{"intervention":670,"totalTrials":11,"cells":671},"Corticosteroid",{"EARLY_PHASE1":672,"PHASE1":674,"PHASE2":676,"PHASE3":678,"PHASE4":680,"NA":682},{"trials":673,"activeCount":49},[],{"trials":675,"activeCount":49},[],{"trials":677,"activeCount":49},[],{"trials":679,"activeCount":49},[],{"trials":681,"activeCount":49},[],{"trials":683,"activeCount":49},[684],{"nctId":685,"briefTitle":686,"status":85,"phases":687,"primaryCompletion":688,"completion":689,"start":690,"enrollment":691,"conditions":692,"interventions":694},"NCT06150378","Comparison Between Platelet Rich Plasma and Corticosteroids for the Treatment of Rotator Cuff Tendinopathy",[43],"2023-08-01","2023-08-31","2022-09-30",100,[693],"Shoulder Tendinopaty",[670,695],"Plathet rich plasma",{"intervention":695,"totalTrials":11,"cells":697},{"EARLY_PHASE1":698,"PHASE1":700,"PHASE2":702,"PHASE3":704,"PHASE4":706,"NA":708},{"trials":699,"activeCount":49},[],{"trials":701,"activeCount":49},[],{"trials":703,"activeCount":49},[],{"trials":705,"activeCount":49},[],{"trials":707,"activeCount":49},[],{"trials":709,"activeCount":49},[710],{"nctId":685,"briefTitle":686,"status":85,"phases":711,"primaryCompletion":688,"completion":689,"start":690,"enrollment":691,"conditions":712,"interventions":713},[43],[693],[670,695],{"intervention":715,"totalTrials":11,"cells":716},"drug interaction",{"EARLY_PHASE1":717,"PHASE1":719,"PHASE2":721,"PHASE3":723,"PHASE4":725,"NA":727},{"trials":718,"activeCount":49},[],{"trials":720,"activeCount":49},[],{"trials":722,"activeCount":49},[],{"trials":724,"activeCount":49},[],{"trials":726,"activeCount":49},[],{"trials":728,"activeCount":49},[729],{"nctId":730,"briefTitle":731,"status":85,"phases":732,"primaryCompletion":733,"completion":734,"start":735,"enrollment":736,"conditions":737,"interventions":739},"NCT04731597","Drug Interactions and Hip Fracture Risk in Older Adults",[],"2020-11-25","2020-12-30","2018-08-16",9721,[738],"Hip Fractures",[715],{"intervention":741,"totalTrials":11,"cells":742},"Ocrelizumab",{"EARLY_PHASE1":743,"PHASE1":745,"PHASE2":747,"PHASE3":749,"PHASE4":751,"NA":753},{"trials":744,"activeCount":49},[],{"trials":746,"activeCount":49},[],{"trials":748,"activeCount":49},[],{"trials":750,"activeCount":49},[],{"trials":752,"activeCount":49},[],{"trials":754,"activeCount":49},[755],{"nctId":756,"briefTitle":757,"status":183,"phases":758,"primaryCompletion":759,"completion":760,"start":761,"enrollment":691,"conditions":762,"interventions":763},"NCT03784547","Real-world Data of Ocrelizumab in Multiple Sclerosis in LATAM",[],"2019-08-01","2019-09-01","2019-02-01",[28],[741],{"intervention":765,"totalTrials":11,"cells":766},"platelet rich plasma",{"EARLY_PHASE1":767,"PHASE1":769,"PHASE2":771,"PHASE3":773,"PHASE4":775,"NA":777},{"trials":768,"activeCount":49},[],{"trials":770,"activeCount":49},[],{"trials":772,"activeCount":49},[],{"trials":774,"activeCount":49},[],{"trials":776,"activeCount":49},[],{"trials":778,"activeCount":49},[779],{"nctId":780,"briefTitle":781,"status":85,"phases":782,"primaryCompletion":783,"completion":783,"start":784,"enrollment":785,"conditions":786,"interventions":788},"NCT04703998","Arthroscopic Rotator Cuff Repair Augmented With Platelet Rich Plasma",[43],"2022-09-01","2021-01-03",103,[787],"Rotator Cuff Tears",[765]]